💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

European shares led higher by tech, banks as US slowdown fears ease

Published 08/15/2024, 03:25 AM
Updated 08/15/2024, 12:40 PM
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 14, 2024.     REUTERS/Staff
UK100
-
ADML
-
STOXX
-
ORSTED
-
ADYEN
-

By Ankika Biswas and Pranav Kashyap

(Reuters) -Technology and bank shares led Europe's benchmark stock index more than 1% higher on Thursday, with risk appetite boosted by strong U.S. retail sales data that eased fears of a slowdown in the world's largest economy.

The pan-European STOXX 600 closed at a two-week high, up 1.2% on the day to complete a reversal of the losses posted during the global market turmoil in the first half of August.

All the major regional bourses, including those of Germany, France, Italy and Spain were also more than 1% higher.

U.S. retail sales rose more than expected in July, keeping investor bets on a smaller than 50-basis-point Federal Reserve interest rate cut intact.

"The numbers should lay to rest - at least for the moment - all of the doom and gloom that was expressed at the beginning of this month," said Chris Zaccarelli, chief investment officer for Independent Advisor Alliance.

"The Fed can begin a rate-cutting cycle without the economy entering recession, and history shows this is an extremely positive environment for the stock market."

Rate-sensitive technology shares, among the hardest hit during the rout, were Thursday's biggest gainers, up 2.6% with semiconductor players such as ASML Holding (AS:ASML) and ASM International (AS:ASMI) leading the way.

The volatility "fear gauge" retreated to its lowest level since late July.

Banks, retail and automobiles were also among the top performers, although most sectors gained on the day.

Dutch payments company Adyen (AS:ADYEN) was the strongest individual performer, jumping 12% to top the STOXX 600 after market share gains helped it beat half-year core profit expectations.

British motor and home insurer Admiral climbed 6.5% after posting a forecast-beating first-half profit.

AstraZeneca (NASDAQ:AZN) rose nearly 2%, marking a record high for a fourth-straight session, after the U.S. Food and Drug Administration granted its blockbuster cancer drug Imfinzi a priority review for patients with limited-stage small cell lung cancer in the United States.

Renewable energy group Orsted (CSE:ORSTED) was the day's worst Stoxx 600 performer, slumping 7.2% after booking 3.9 billion Danish crowns ($574.4 million) in impairment losses in second quarter.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 14, 2024.     REUTERS/Staff

Swedish games developer Embracer fell more than 7% after a reporting a 50% drop in first-quarter operating profit, and Swiss plumbing materials supplier Geberit (SIX:GEBN) lost nearly 2% after disappointing with a forecast for 2024 organic sales similar to those of last year.

($1 = 6.7899 Danish crowns)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.